Rebiotix, Seres, Vedanta form microbiome policy group

Rebiotix Inc. (Roseville, Minn.), Seres Therapeutics Inc. (NASDAQ:MCRB) and Vedanta Biosciences Inc. (Cambridge, Mass.) formed the Microbiome Therapeutics Innovation Group (MTIG), an advocacy group for microbiome medicines.

The coalition’s stated policy objectives are streamlining and clarifying the clinical and regulatory process for approving microbiome drugs, educating policymakers and the public on the microbiome’s role in health, and encouraging FDA to finalize March 2016 draft guidance on the use of fecal microbiota for transplantation in drug-resistant Clostridium difficile infection...